Denosumab for Prevention of Acute Onset Immobilization‐Induced Alterations of Bone Turnover: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Denosumab for Prevention of Acute Onset Immobilization‐Induced Alterations of Bone Turnover: A Randomized Controlled Trial

Published:2022-09-23 Issue:11 Volume:37 Page:2156-2164
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Wadiura Lisa Irina¹,Butylina Maria²,Reinprecht Andrea¹,Aretin Marie‐Bernadette³,Mischkulnig Mario¹,Gleiss Andreas⁴,Pietschmann Peter²,Kerschan‐Schindl Katharina⁵^ORCID

Affiliation:

1. Department of Neurosurgery Medical University of Vienna Vienna Austria

2. Institute of Pathophysiology and Allergy Research Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna Vienna Austria

3. Pharmacy Department General Hospital of Vienna Vienna Austria

4. Center of Medical Statistics, Informatics, and Intelligent Systems Medical University of Vienna Vienna Austria

5. Department of Physical Medicine Rehabilitation and Occupational Medicine, Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4694

Reference41 articles.

1. Bone resorption is induced on the second day of bed rest: results of a controlled crossover trial

2. Discordant recovery of bone mass and mechanical properties during prolonged recovery from disuse